-resistant lines are being used to test the "resistance-breaking" efficacy of active compounds early in their development.
No takes yet. Share an insight, caveat, or question.
Adolfi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: